These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients. Fioretto P; Frigato F; Velussi M; Riva F; Muollo B; Carraro A; Brocco E; Cipollina MR; Abaterusso C; Trevisan M Am J Hypertens; 1992 Nov; 5(11):837-46. PubMed ID: 1457087 [TBL] [Abstract][Full Text] [Related]
7. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension. Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319 [TBL] [Abstract][Full Text] [Related]
8. Effect of a new angiotensin converting enzyme inhibitor, cilazapril, on circulating atrial natriuretic factor during exercise in patients with essential hypertension. Kohno M; Yasunari K; Murakawa K; Yokokawa K; Horio T; Kurihara N; Takeda T J Hypertens Suppl; 1989 Dec; 7(6):S298-9. PubMed ID: 2534417 [TBL] [Abstract][Full Text] [Related]
9. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide. Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714 [TBL] [Abstract][Full Text] [Related]
10. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading. Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440 [TBL] [Abstract][Full Text] [Related]
11. [Arterial hypertension in diabetes mellitus]. Tiengo A G Clin Med; 1990 Jan; 71(1):3-6, 10-6. PubMed ID: 2142112 [No Abstract] [Full Text] [Related]
12. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes. Breithaupt K; Belz GG; Spielmanns DG; Neis W; Kirchner P Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):136-41. PubMed ID: 2159308 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and effects on renal function following cilazapril and hydrochlorothiazide alone and in combination in healthy subjects and hypertensive patients. Nilsen OG; Sellevold OF; Romfo OS; Smedsrud A; Grynne B; Williams PE; Kleinbloesem CH Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):323S-328S. PubMed ID: 2527546 [TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function. Shionoiri H; Gotoh E; Takagi N; Takeda K; Yabana M; Kaneko Y J Cardiovasc Pharmacol; 1988 Feb; 11(2):242-9. PubMed ID: 2452321 [TBL] [Abstract][Full Text] [Related]
15. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen. Fernandez PG; Bolli P; Lee C Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051 [TBL] [Abstract][Full Text] [Related]
16. Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy. Parving HH J Diabetes Complications; 1996; 10(3):133-5. PubMed ID: 8807457 [TBL] [Abstract][Full Text] [Related]
17. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril. Waeber B; Weidmann P; Wohler D; Le Bloch Y Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894 [TBL] [Abstract][Full Text] [Related]